Though AD patients were found with peripheral hyperinsulinemia, AD patients have reduced levels of insulin in the cerebrospinal fluid (CSF), indicating that insulin signaling activities may be below the normal threshold in the brain [16]. This evidence concerns the gene INS and Alzheimer disease.